Modafinil Tablet
FDA Label NDC 70771-1052

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Modafinil (NDC 70771-1052). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1051-3

Modafinil Tablets USP, 100 mg

30 Tablets

Rx only

Modafinil Tablets Usp, 100mg And 200mg (E22df34a 3c16 4062 9882 Be9840afb8cf 01)

Modafinil Tablets Usp, 100mg And 200mg (E22df34a 3c16 4062 9882 Be9840afb8cf 01)

NDC 70771-1052-3

Modafinil Tablets USP, 200 mg

30 Tablets

Rx only

Modafinil Tablets Usp, 100mg And 200mg (E22df34a 3c16 4062 9882 Be9840afb8cf 02)

Modafinil Tablets Usp, 100mg And 200mg (E22df34a 3c16 4062 9882 Be9840afb8cf 02)

* Please review the disclaimer below.